These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7884404)

  • 1. Adenosine--an endogenous neuroprotective metabolite and neuromodulator.
    Deckert J; Gleiter CH
    J Neural Transm Suppl; 1994; 43():23-31. PubMed ID: 7884404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective role of adenosine in the CNS.
    Wardas J
    Pol J Pharmacol; 2002; 54(4):313-26. PubMed ID: 12523485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacology; 2007; 79(3):171-83. PubMed ID: 17377417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perspectives on the therapy of neuropsychiatric diseases with adenosinergic substances].
    Erfurth A; Schmauss M
    Fortschr Neurol Psychiatr; 1995 Mar; 63(3):93-8. PubMed ID: 7759049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of adenosine in the central nervous system].
    Zhang WL; Lu GW
    Sheng Li Ke Xue Jin Zhan; 1996 Oct; 27(4):313-8. PubMed ID: 9772380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative characteristics of A1-receptor agonists as neuroprotective agents].
    Kulinskiĭ VI; Minakina LN; Usov LA
    Eksp Klin Farmakol; 2001; 64(5):19-22. PubMed ID: 11764492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
    Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
    J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine and neuroprotection.
    Fredholm BB
    Int Rev Neurobiol; 1997; 40():259-80. PubMed ID: 8989624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
    Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
    Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
    Tebano MT; Pintor A; Frank C; Domenici MR; Martire A; Pepponi R; Potenza RL; Grieco R; Popoli P
    J Neurosci Res; 2004 Jul; 77(1):100-7. PubMed ID: 15197743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The mechanisms of depression by benzodiazepines, barbiturates and propofol of excitatory synaptic transmissions mediated by adenosine neuromodulation].
    Narimatsu E; Niiya T; Kawamata M; Namiki A
    Masui; 2006 Jun; 55(6):684-91. PubMed ID: 16780077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.
    Stone TW; Ceruti S; Abbracchio MP
    Handb Exp Pharmacol; 2009; (193):535-87. PubMed ID: 19639293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of action of neuroprotectants in stroke.
    Lyden P; Wahlgren NG
    J Stroke Cerebrovasc Dis; 2000 Nov; 9(6 Pt 2):9-14. PubMed ID: 17895214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A1 and A2 receptor agonists reduce endotoxin-induced cellular energy depletion and oedema formation in the lung.
    Heller AR; Rothermel J; Weigand MA; Plaschke K; Schmeck J; Wendel M; Bardenheuer HJ; Koch T
    Eur J Anaesthesiol; 2007 Mar; 24(3):258-66. PubMed ID: 17094869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine receptors--the role in modulation of dopamine and glutamate release in the rat striatum.
    Gołembiowska K; Zylewska A
    Pol J Pharmacol; 1997; 49(5):317-22. PubMed ID: 9566030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects.
    Knutsen LJ; Lau J; Petersen H; Thomsen C; Weis JU; Shalmi M; Judge ME; Hansen AJ; Sheardown MJ
    J Med Chem; 1999 Sep; 42(18):3463-77. PubMed ID: 10479279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease.
    Kalda A; Yu L; Oztas E; Chen JF
    J Neurol Sci; 2006 Oct; 248(1-2):9-15. PubMed ID: 16806272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of glial cell functions by adenosine receptors.
    Daré E; Schulte G; Karovic O; Hammarberg C; Fredholm BB
    Physiol Behav; 2007 Sep; 92(1-2):15-20. PubMed ID: 17574632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adenosine--neurotransmitter and neuromodulator in the central nervous system].
    Romanowska M; Komoszyński M
    Postepy Biochem; 2002; 48(3):230-8. PubMed ID: 12625251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.